CA - Lilly Novo Nordisk diabetes drugs see price raises - report
2024-01-18 14:41:08 ET
More on Eli Lilly, Novo Nordisk
- Taking Novo Nordisk To The Next Level
- Novo Nordisk: Enjoying The Tailwinds Of A Growing Market
- Eli Lilly: The Buzz Is Not Over
- Eli Lilly’s Jaypirca to lead BTK inhibitor market for leukemia
- Novo Nordisk resumes U.S. shipments of Wegovy 1.7 mg dose
For further details see:
Lilly, Novo Nordisk diabetes drugs see price raises - report